Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Antiparasitic Drugs Market CAGR Outlook And Future Development
The antiparasitic drugs market has shown substantial growth in recent years. It is projected to expand from $25.58 billion in 2025 to $27.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. The historical increase in this market can be attributed to the rising prevalence of parasitic diseases, restricted access to modern antiparasitic drugs in developing regions, a long-standing reliance on monotherapy drugs, growing demand for veterinary care, and inadequate awareness concerning preventive measures.
The size of the antiparasitic drugs market is projected to experience substantial expansion in the coming years. This market is set to reach $36.13 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. The anticipated expansion during this period can be ascribed to several factors, including increased adoption of combination therapy, progress in precision medicine for parasitic infections, a heightened emphasis on animal health and livestock safeguarding, the widening of emerging markets, and the creation of innovative delivery mechanisms for antiparasitic drugs. Key trends anticipated during the forecast timeframe encompass a rising occurrence of parasitic infections, the evolution of combination antiparasitic drugs, an increase in animal healthcare uses, a preference shift towards oral and injectable treatments, and the appearance of new antiparasitic agents.
Get A Free Sample Report With In-Depth Market Insights:
Antiparasitic Drugs Market Industry Drivers: What’s Behind The Revenue Growth?
The rising occurrence of vector-borne diseases is anticipated to drive the expansion of the antiparasitic drugs market in the future. These are defined as infectious illnesses spread to humans or animals via arthropod bites, mainly from insects such as mosquitoes, ticks, and flies. Notable examples of such diseases include malaria, dengue, and yellow fever. Antiparasitic drugs are crucial in preventing the dissemination of vector-borne diseases by targeting and eradicating the causative parasites. Certain antiparasitic medications, such as chloroquine, doxycycline, and atovaquone-proguanil, are frequently administered for malaria treatment. As an illustration, data from the Centers for Disease Control and Prevention, a US-based Government agency, for June 2024 indicates that from January to June 2024, the Americas saw over 9.7 million dengue cases, which is more than twice the 4.6 million cases reported in 2023. Within the United States, Puerto Rico recorded 1,498 dengue cases, and an additional 745 cases were found among U.S. travelers returning from regions where the disease is prevalent. Consequently, the rising prevalence of vector-borne diseases is a key factor propelling the expansion of the antiparasitic drugs market.
Antiparasitic Drugs Market Segment Trends And Revenue Contributors
The antiparasitic drugs market covered in this report is segmented –
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents
#Antiparasitic Drugs Market Growth Trends: What’s Shaping The Future Outlook?
Major companies within the antiparasitic drugs market are concentrating on developing innovative products, such as chewable veterinary items, to improve ease of administration and increase pet compliance. These chewable veterinary products are flavored, simple-to-administer tablets or treats specifically designed to deliver medication to animals. They boost pet compliance by making the treatment process more palatable and less stressful. For example, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a Germany-based pharmaceutical company, introduced NexGard Spectra to provide comprehensive parasite control. NexGard SPECTRA is a soft, flavorful chew that offers complete internal and external parasite protection for dogs, effectively targeting fleas, ticks, heartworms, and various intestinal worms in a single monthly dose. It demonstrates rapid action, killing fleas within four hours of administration and achieving over 99% effectiveness against multiple parasites shortly thereafter.
Antiparasitic Drugs Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim Group, Zoetis Inc., Eisai Co. Ltd., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Santé Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier
View The Full Antiparasitic Drugs Market Report:
Antiparasitic Drugs Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the antiparasitic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antiparasitic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
